Boehringer Ingelheim Adopts Virtuosi VR Education Platform
Boehringer Ingelheim will use Virtuosi to train employees at three aseptic sites across its network.
Quality Executive Partners (QxP), global management consulting and educational technology firm, announced on Sept. 20, 2022 that Boehringer Ingelheim has officially deployed its Virtuosi VR education platform for employee training. Boehringer Ingelheim is set to deploy the technology at three aseptic sites across its network.
Virtuosi is a cloud-based learning platform that incorporates 56 courses and 26 VR immersive experiences in more than 100 hours of educational content. According to a company press, its modules are self-paced and fully learning management software-integrated for reporting and evaluation. Additionally, learners receive real-time coaching via responsive formative evaluation, coaching, and haptic feedback.
"QxP is proud to partner with Boehringer Ingelheim, a leading research-driven biopharmaceutical company. Virtuosi is helping Boehringer Ingelheim to further advance the skills and knowledge necessary in sterile manufacturing using tech-forward innovation," said Crystal Mersh, CEO, QxP, in the release.
Source: Quality Executive Partners
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Prokaryotics Licenses Gram-Negative Antibiotic Potentiator from Northern Antibiotics
June 26th 2025Prokaryotics will gain worldwide rights to develop, manufacture, and commercialize NAB741, a non-bioactive polymyxin designed to increase permeability of the outer membrane of Gram-negative bacteria.
